279 related articles for article (PubMed ID: 17221852)
1. Perioperative outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy for non-appendiceal peritoneal carcinomatosis from a prospective database.
Yan TD; Zappa L; Edwards G; Alderman R; Marquardt CE; Sugarbaker PH
J Surg Oncol; 2007 Aug; 96(2):102-12. PubMed ID: 17221852
[TBL] [Abstract][Full Text] [Related]
2. Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma--a prospective study of 70 consecutive cases.
Yan TD; Edwards G; Alderman R; Marquardt CE; Sugarbaker PH
Ann Surg Oncol; 2007 Feb; 14(2):515-25. PubMed ID: 17031722
[TBL] [Abstract][Full Text] [Related]
3. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy.
Sugarbaker PH; Alderman R; Edwards G; Marquardt CE; Gushchin V; Esquivel J; Chang D
Ann Surg Oncol; 2006 May; 13(5):635-44. PubMed ID: 16523363
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
[TBL] [Abstract][Full Text] [Related]
5. Postoperative infections in cytoreductive surgery with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis.
Capone A; Valle M; Proietti F; Federici O; Garofalo A; Petrosillo N
J Surg Oncol; 2007 Nov; 96(6):507-13. PubMed ID: 17708508
[TBL] [Abstract][Full Text] [Related]
6. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis: initial experience in Oaxaca, Mexico.
García-Matus R; Hernández-Hernández CA; Leyva-García O; Vásquez-Ciriaco S; Flores-Ayala G; Navarro-Hernández Q; Pérez-Bustamante G; Valencia-Mijares NM; Esquivel J
Am Surg; 2012 Sep; 78(9):942-6. PubMed ID: 22964201
[TBL] [Abstract][Full Text] [Related]
7. Morbidity and mortality outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy at a single tertiary institution: towards a new perspective of this treatment.
Chua TC; Saxena A; Schellekens JF; Liauw W; Yan TD; Fransi S; Zhao J; Morris DL
Ann Surg; 2010 Jan; 251(1):101-6. PubMed ID: 19838105
[TBL] [Abstract][Full Text] [Related]
8. Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy--a journey to becoming a Nationally Funded Peritonectomy Center.
Yan TD; Links M; Fransi S; Jacques T; Black D; Saunders V; Morris DL
Ann Surg Oncol; 2007 Aug; 14(8):2270-80. PubMed ID: 17464543
[TBL] [Abstract][Full Text] [Related]
9. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy.
Jacquet P; Stephens AD; Averbach AM; Chang D; Ettinghausen SE; Dalton RR; Steves MA; Sugarbaker PH
Cancer; 1996 Jun; 77(12):2622-9. PubMed ID: 8640714
[TBL] [Abstract][Full Text] [Related]
10. Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with primary and recurrent advanced ovarian cancer.
Cascales Campos P; Gil J; Parrilla P
Eur J Surg Oncol; 2014 Aug; 40(8):970-5. PubMed ID: 24035502
[TBL] [Abstract][Full Text] [Related]
11. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients.
Glehen O; Gilly FN; Boutitie F; Bereder JM; Quenet F; Sideris L; Mansvelt B; Lorimier G; Msika S; Elias D;
Cancer; 2010 Dec; 116(24):5608-18. PubMed ID: 20737573
[TBL] [Abstract][Full Text] [Related]
12. Critical assessment of preoperative and operative risk factors for complications after iterative peritonectomy procedures.
Saxena A; Yan TD; Morris DL
Eur J Surg Oncol; 2010 Mar; 36(3):309-14. PubMed ID: 19615849
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis.
Klaver YL; Chua TC; de Hingh IH; Morris DL
J Surg Oncol; 2012 Feb; 105(2):113-8. PubMed ID: 21780124
[TBL] [Abstract][Full Text] [Related]
14. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival.
Hagendoorn J; van Lammeren G; Boerma D; van der Beek E; Wiezer MJ; van Ramshorst B
Eur J Surg Oncol; 2009 Aug; 35(8):833-7. PubMed ID: 19019619
[TBL] [Abstract][Full Text] [Related]
15. Indication of peritonectomy for peritoneal dissemination.
Yonemura Y; Tsukiyama G; Miyata R; Sako S; Endou Y; Hirano M; Mizumoto A; Matsuda T; Takao N; Ichinose M; Miura M; Hagiwara A; Li Y
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2306-11. PubMed ID: 21224556
[TBL] [Abstract][Full Text] [Related]
16. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival.
Yan TD; Chu F; Links M; Kam PC; Glenn D; Morris DL
Eur J Surg Oncol; 2006 Dec; 32(10):1119-24. PubMed ID: 16887321
[TBL] [Abstract][Full Text] [Related]
17. Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
Piso P; Slowik P; Popp F; Dahlke MH; Glockzin G; Schlitt HJ
Ann Surg Oncol; 2009 Aug; 16(8):2188-94. PubMed ID: 19408049
[TBL] [Abstract][Full Text] [Related]
18. Evolution of locoregional treatment for peritoneal carcinomatosis: single-center experience of 308 procedures of cytoreductive surgery and perioperative intraperitoneal chemotherapy.
Chua TC; Liauw W; Saxena A; Al-Mohaimeed K; Fransi S; Zhao J; Morris DL
Am J Surg; 2011 Feb; 201(2):149-56. PubMed ID: 20832051
[TBL] [Abstract][Full Text] [Related]
19. [Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy associated toxicity in treatment of peritoneal carcinomatosis].
Mancebo-González A; Díaz-Carrasco MS; Cascales-Campos P; de la Rubia A; Gil Martínez J
Farm Hosp; 2012; 36(2):60-7. PubMed ID: 21514864
[TBL] [Abstract][Full Text] [Related]
20. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
